81 – 90 of 304
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Risk Factors That Affect Life Expectancy in Alzheimer's Disease: A 15-Year Follow-Up.
(
- Contribution to journal › Article
-
Mark
Increased Levels of Hyaluronic Acid in Cerebrospinal Fluid in Patients with Vascular Dementia.
(
- Contribution to journal › Article
-
Mark
Low Levels of Soluble NG2 in Cerebrospinal Fluid from Patients with Dementia with Lewy Bodies.
2014) In Journal of Alzheimer's Disease(
- Contribution to journal › Article
-
Mark
Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease.
(
- Contribution to journal › Article
-
Mark
Factors that affect life-span in mild versus moderate Alzheimer’s disease.
2014) 13th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy In Neurobiology of Aging 35(Suppl. 1). p.25-25(
- Contribution to journal › Published meeting abstract
-
Mark
Early- versus Late-onset Alzheimer’s Disease—3-year Outcomes of Cholinesterase Inhibitor Treatment in Routine Clinical Practice.
2014) 7th Clinical Trials Conference on Alzheimer’s Disease (CTAD)(
- Contribution to conference › Poster
-
Mark
The effect of functional capacity and concomitant medications on life expectancy in Alzheimer’s disease.
2014) Alzheimer’s Association International Conference (AAIC), 2014(
- Contribution to conference › Poster
-
Mark
Prevalence of Lewy body dementia and neuroleptic treatment in nursing homes in Malmö, Sweden.
2014) Alzheimer’s Association International Conference (AAIC), 2014(
- Contribution to conference › Poster
-
Mark
White matter hyperintensities as a confounder in diffusion tensor imaging analysis of elderly cohorts
2014) ISMRM-ESMRMB(
- Contribution to conference › Abstract
- 2013
-
Mark
Evaluating Amyloid-beta Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease
(
- Contribution to journal › Article